Gemmati, D.; D’Aversa, E.; Antonica, B.; Grisafi, M.; Salvatori, F.; Pizzicotti, S.; Pellegatti, P.; Ciccone, M.; Moratelli, S.; Serino, M.L.;
et al. Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy. Genes 2024, 15, 432.
https://doi.org/10.3390/genes15040432
AMA Style
Gemmati D, D’Aversa E, Antonica B, Grisafi M, Salvatori F, Pizzicotti S, Pellegatti P, Ciccone M, Moratelli S, Serino ML,
et al. Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy. Genes. 2024; 15(4):432.
https://doi.org/10.3390/genes15040432
Chicago/Turabian Style
Gemmati, Donato, Elisabetta D’Aversa, Bianca Antonica, Miriana Grisafi, Francesca Salvatori, Stefano Pizzicotti, Patrizia Pellegatti, Maria Ciccone, Stefano Moratelli, Maria Luisa Serino,
and et al. 2024. "Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy" Genes 15, no. 4: 432.
https://doi.org/10.3390/genes15040432
APA Style
Gemmati, D., D’Aversa, E., Antonica, B., Grisafi, M., Salvatori, F., Pizzicotti, S., Pellegatti, P., Ciccone, M., Moratelli, S., Serino, M. L., & Tisato, V.
(2024). Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy. Genes, 15(4), 432.
https://doi.org/10.3390/genes15040432